Patents by Inventor Jama Pitman

Jama Pitman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS
    Publication number: 20250367176
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 30, 2025
    Publication date: December 4, 2025
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 12318373
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 21, 2024
    Date of Patent: June 3, 2025
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 12295944
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 21, 2024
    Date of Patent: May 13, 2025
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS
    Publication number: 20240342145
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof. comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 21, 2024
    Publication date: October 17, 2024
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS
    Publication number: 20240342144
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 21, 2024
    Publication date: October 17, 2024
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 12059411
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 2, 2023
    Date of Patent: August 13, 2024
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 12059410
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 2, 2023
    Date of Patent: August 13, 2024
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 12023327
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 2, 2023
    Date of Patent: July 2, 2024
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 12023326
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 2, 2023
    Date of Patent: July 2, 2024
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 12023325
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 2, 2023
    Date of Patent: July 2, 2024
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 11969414
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: April 30, 2024
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS
    Publication number: 20240082226
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 2, 2023
    Publication date: March 14, 2024
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS
    Publication number: 20240082227
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 2, 2023
    Publication date: March 14, 2024
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS
    Publication number: 20240075020
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 2, 2023
    Publication date: March 7, 2024
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS
    Publication number: 20240075019
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 2, 2023
    Publication date: March 7, 2024
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS
    Publication number: 20240075018
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 2, 2023
    Publication date: March 7, 2024
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 11813251
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 30, 2022
    Date of Patent: November 14, 2023
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS
    Publication number: 20230145926
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 30, 2022
    Publication date: May 11, 2023
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 11576904
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 3, 2022
    Date of Patent: February 14, 2023
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman
  • Methods of treating gastrointestinal stromal tumors
    Patent number: 11534432
    Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 22, 2022
    Date of Patent: December 27, 2022
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Rodrigo Ruiz Soto, Oliver Rosen, Jama Pitman